Polymerase ε1 mutation in a human syndrome with facial dysmorphism, immunodeficiency, livedo, and short stature (“FILS syndrome”)

J Pachlopnik Schmid, R Lemoine, N Nehme… - Journal of Experimental …, 2012 - rupress.org
J Pachlopnik Schmid, R Lemoine, N Nehme, V Cormier-Daire, P Revy, F Debeurme…
Journal of Experimental Medicine, 2012rupress.org
DNA polymerase ε (Polε) is a large, four-subunit polymerase that is conserved throughout
the eukaryotes. Its primary function is to synthesize DNA at the leading strand during
replication. It is also involved in a wide variety of fundamental cellular processes, including
cell cycle progression and DNA repair/recombination. Here, we report that a homozygous
single base pair substitution in POLE1 (polymerase ε 1), encoding the catalytic subunit of
Polε, caused facial dysmorphism, immunodeficiency, livedo, and short stature (“FILS …
DNA polymerase ε (Polε) is a large, four-subunit polymerase that is conserved throughout the eukaryotes. Its primary function is to synthesize DNA at the leading strand during replication. It is also involved in a wide variety of fundamental cellular processes, including cell cycle progression and DNA repair/recombination. Here, we report that a homozygous single base pair substitution in POLE1 (polymerase ε 1), encoding the catalytic subunit of Polε, caused facial dysmorphism, immunodeficiency, livedo, and short stature (“FILS syndrome”) in a large, consanguineous family. The mutation resulted in alternative splicing in the conserved region of intron 34, which strongly decreased protein expression of Polε1 and also to a lesser extent the Polε2 subunit. We observed impairment in proliferation and G1- to S-phase progression in patients’ T lymphocytes. Polε1 depletion also impaired G1- to S-phase progression in B lymphocytes, chondrocytes, and osteoblasts. Our results evidence the developmental impact of a Polε catalytic subunit deficiency in humans and its causal relationship with a newly recognized, inherited disorder.
rupress.org